Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis - Wikidata - wikimedia - TriplyDB

Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis

Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis

http://www.wikidata.org/entity/Q35553944

about

Resolution of inflammation: an integrated view Nanomedicine delivers promising treatments for rheumatoid arthritis Development of macromolecular prodrug for rheumatoid arthritis Separating therapeutic efficacy from glucocorticoid side-effects in rodent arthritis using novel, liposomal delivery of dexamethasone phosphate: long-term suppression of arthritis facilitates interval treatment Pharmacokinetic and biodistribution studies of N-(2-hydroxypropyl)methacrylamide copolymer-dexamethasone conjugates in adjuvant-induced arthritis rat model.Liposomal encapsulation enhances and prolongs the anti-inflammatory effects of water-soluble dexamethasone phosphate in experimental adjuvant arthritis.Glucocorticoid-targeted therapies for the treatment of rheumatoid arthritis.Liposomal targeting of prednisolone phosphate to synovial lining macrophages during experimental arthritis inhibits M1 activation but does not favor M2 differentiation.Novel dexamethasone-HPMA copolymer conjugate and its potential application in treatment of rheumatoid arthritis.Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration.Liposomes in the treatment of inflammatory disorders.Cells of the synovium in rheumatoid arthritis. Macrophages.The Development of Novel Therapies for Rheumatoid Arthritis Synthesis and evaluation of a well-defined HPMA copolymer-dexamethasone conjugate for effective treatment of rheumatoid arthritis.Fabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivo.Nanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes.Designing micro- and nano-particles for treating rheumatoid arthritis.A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis.The use of lipid-based nanocarriers for targeted pain therapies.Recent advances in nanomedicines for the treatment of rheumatoid arthritis.Radionuclide imaging of liposomal drug delivery.Biodistribution of Fracture-Targeted GSK3β Inhibitor-Loaded Micelles for Improved Fracture Healing.Selectively induced death of macrophages in the synovial lining of murine knee joints using 10B-liposomes and boron neutron capture synovectomy.Co-encapsulation of dexamethasone 21-acetate and SPIONs into biodegradable polymeric microparticles designed for intra-articular delivery.Fracture-Targeted Delivery of β-Catenin Agonists via Peptide-Functionalized Nanoparticles Augments Fracture Healing.Liposomal nano-drugs based on amphipathic weak acid steroid prodrugs for treatment of inflammatory diseases.Lipid-Based Nanoparticles as a Potential Delivery Approach in the Treatment of Rheumatoid Arthritis.Evaluation of subconjunctival liposomal steroids for the treatment of experimental uveitis.Designing Lipid Nanostructures for Local Delivery of Biologically Active Macromolecules Application of liposomes in treatment of rheumatoid arthritis: quo vadis

P2860

Q26852569-80EA1D08-B4B7-410C-9C31-AD791B600438 Q27021438-467B1E34-9D30-4F6F-8C7B-3AEBF9A9E705 Q27693332-9C06F7CD-B5CA-418B-9CB3-E04BF9E93F3B Q30318833-69C7CDE0-3A6C-4EDC-A3DD-EFE6B0E1169D Q30495832-89ECC0DF-7BAE-4CC2-B201-C73B1628783C Q34153033-962466C2-3C95-448F-84C3-E594F5A064F8 Q34548430-9E399913-FA17-48F6-8F73-758A5254F60D Q34611331-C0430C2F-85CE-4C46-AE97-8F864DC47BAD Q35769042-2C330F70-37B6-4337-A58E-51B285ADE046 Q36223678-442F098E-8C62-442D-9714-EA5C6514F742 Q36316769-D6C72538-6D9A-427B-81F7-DCEA3558C89C Q36465497-034484CA-959B-43D9-B13E-C1D37286F935 Q36801049-8EBD66B8-C0F0-4C00-BF81-F10180BF97A0 Q36994094-184547BA-0B71-4E5E-AED9-EF0DE9956D04 Q37003881-15CD8EA8-1EAC-40F1-A760-1A775C4B7310 Q37627094-95EC5FA0-4047-4B4D-92B8-0644F76E5EB7 Q37964579-1DFA4AF2-888A-40A6-9CFF-30CA43F928BF Q38071913-EEA1A195-92F7-47C8-9802-D9CF32FDF552 Q38169707-702E4AEA-1386-4560-A606-79115835E800 Q38669113-9BBCF9D4-D259-49DC-A5E8-23D2AFE4FFA6 Q38879338-7F481CE5-77C0-454E-B461-1E2DC61BCF11 Q39254173-607E7904-517A-4F57-9745-2330CA64D43B Q39959544-E60A2FA4-210E-4933-B657-3E06CCA02DB6 Q43849342-0CB3FF4E-1030-439C-B336-E44D2871B858 Q47142933-1B786402-A744-45D6-B2CB-180087CBBCB6 Q47975293-BA626992-34DA-4E04-AB7D-5D65D1640FB3 Q48225327-3E4E16DE-F11C-4C6B-B22F-8556FEE9D34F Q55176472-4501715F-2974-4FD5-813E-CA353C292153 Q58867355-3A40DA6B-A51B-4A83-A930-1A0BE9DC260C Q59101195-94E49E1C-BE30-4103-AC00-8E41FF06A4DF

P2860

Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis

http://www.wikidata.org/entity/Q35553944

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Liposomal targeting of glucoco ...... in collagen type II arthritis

@ast

Liposomal targeting of glucoco ...... in collagen type II arthritis

@en

type

label

Liposomal targeting of glucoco ...... in collagen type II arthritis

@ast

Liposomal targeting of glucoco ...... in collagen type II arthritis

@en

prefLabel

Liposomal targeting of glucoco ...... in collagen type II arthritis

@ast

Liposomal targeting of glucoco ...... in collagen type II arthritis

@en

P1433

Q35553944-92C3F35B-AF49-430F-B017-6C19ADAD1C81

P1476

Q35553944-924E689A-D431-41BA-9FC1-D78811567CB0

P2093

Q35553944-12B4F9CB-A224-4B81-94A6-886700AF0511

Q35553944-27ABA171-1D8E-43FE-9B34-36DA40488B54

Q35553944-7F9B99CD-5ED2-49EB-8818-FFCA1A2945BC

Q35553944-A3E187D0-3554-4AF8-A6E7-29A3BE3CA16D

Q35553944-C9EF1198-437C-4187-916A-8F3E55F10A74

Q35553944-D654A644-2782-49A5-8A62-225C5437DFE9

P2860

Q35553944-0A320C1C-AB76-4AD0-8AFC-26174C4F123A

Q35553944-0FCD9ED2-000E-44CB-9EE7-A599BC4F7395

Q35553944-186E3759-F277-4921-8F53-4E26967E6D23

Q35553944-33297D4D-3186-4D7F-9D2C-20CF46FB5574

Q35553944-3375C4BE-0594-4B36-AD87-122CE557C2F3

Q35553944-3C8F7F27-AE07-431A-992C-07E8544CB275

Q35553944-3EF27BBC-3B3B-4766-B6FC-B712D92AAC9A

Q35553944-67BDF2D0-5AFB-4318-B446-161D7956B2A5

Q35553944-70BAC468-E095-4DE4-ACFF-42E60AFC0A63

Q35553944-71CA4CBC-9FF0-486C-A7C3-9205F4E42724

P304

Q35553944-81D3B574-D80B-4A5D-9F18-29ABE9E8D0D2

P31

Q35553944-41950095-A5AD-4DEF-969B-64F191CA08AB

P356

Q35553944-F1AF2AA0-EC45-48A0-93CD-66D7427AC4DF

P407

Q35553944-C1E5D2DD-D006-418B-BCA2-E0CAC557FB37

P433

Q35553944-E0B79190-C926-4D20-889D-32E8CB76A201

P478

Q35553944-813B7721-3A0C-4424-933D-F03EFA3F3450

P577

Q35553944-35CFCBB4-337B-4D4A-BED8-C6822FFF4708

P5875

Q35553944-E1AC70A7-D5B3-4370-8E53-47B1610E8189

P698

Q35553944-F36BBE0A-67DD-4F0E-87F0-5EFD8DD21801

P932

Q35553944-AC37E3AC-259E-4405-B50E-C158CE27C2EE

P356

ARD.2003.009944

P1433

Annals of the Rheumatic Diseases

P1476

Liposomal targeting of glucoco ...... in collagen type II arthritis

@en

P2093

Holthuysen AE

http://www.w3.org/2001/XMLSchema#string

Metselaar JM

http://www.w3.org/2001/XMLSchema#string

Storm G

http://www.w3.org/2001/XMLSchema#string

Wauben MH

http://www.w3.org/2001/XMLSchema#string

van Lent PL

http://www.w3.org/2001/XMLSchema#string

van den Berg WB

http://www.w3.org/2001/XMLSchema#string

P2860

Macrophages in rheumatoid arthritis

Combination of methylprednisolone pulse therapy and remission inducing drugs in rheumatoid arthritis.

Targets of glucocorticoid action on TNF-alpha release by macrophages.

Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages.

Glucocorticoid use in rheumatoid arthritis.

Sterically stabilized liposomes.

Rheumatoid arthritis. Pathophysiology and implications for therapy.

Long-circulating liposomes.

Role of macrophage-like synovial lining cells in localization and expression of experimental arthritis.

Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications.

P304

348-353

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ARD.2003.009944

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P577

2004-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5331135

http://www.w3.org/2001/XMLSchema#string

P698

15020326

http://www.w3.org/2001/XMLSchema#string

P932

1754935

http://www.w3.org/2001/XMLSchema#string